SERPINB2 and Hyperinsulinemia: The consequences of insulin resistance and its compensatory hyperinsulinemia include glucose intolerance, dyslipidemia (increased TG and/or decreased HDL-C), high blood pressure, hyperuricemia, and increased plasminogen activator inhibitor (PAI)-1 activity [23].